Take Five: Clinical Education - "Hepatitis C for Primary Care Providers" 8/12/15 |
Take Five Purpose/Description
Take Five is a mini clinical education session designed to take 5 minutes to complete. Each Take Five includes 5 questions related to the topic being highlighted. The participant is asked to answer a simple multiple choice question in a survey format. After the answer is submitted, the correct answer for each question along with the rationale and information on how to link with the source information if you would like a more in-depth review of the information. The topics will be varied and may not apply to every person, every time, but they are designed to be shared within your organization as you wish.
Hepatitis C is the leading cause of liver transplant in the United States. It is also a common cause of cirrhosis (a chronic disease of the liver caused by degeneration of cells and inflammation) and hepatocellular carcinoma (cancer arising from liver cells). “An estimated 4.1 million individuals, or 1.6% of the population, are infected nationwide, many of whom are unaware of the infection since it is often asymptomatic” (Huffman & Mounsey, 2014).
The material for this review comes from the following:
• Dhawan, MD, V. (2015). Hepatitis C Treatment & Management (B. Anand, MD, Ed.). Medscape, 1-15. Retrieved August 6, 2015, from http://emedicine.medscape.com/article/177792-treatment
• Huffman, M., & Mounsey, A. (2014). Hepatitis C for Primary Care Physicians. The Journal of the American Board of Family Medicine, 27(2), 284-291. Retrieved August 6, 2015, from http://www.jabfm.org/content/27/2/284.full
• Reau, N., & Graham, L. (2015). Hepatitis C: Screening, Identification, and Care. Digestive Disease Week, 1-5. Retrieved August 6, 2015, from http://www.medscape.com/viewarticle/848249
Hepatitis C is the leading cause of liver transplant in the United States. It is also a common cause of cirrhosis (a chronic disease of the liver caused by degeneration of cells and inflammation) and hepatocellular carcinoma (cancer arising from liver cells). “An estimated 4.1 million individuals, or 1.6% of the population, are infected nationwide, many of whom are unaware of the infection since it is often asymptomatic” (Huffman & Mounsey, 2014).
The material for this review comes from the following:
• Dhawan, MD, V. (2015). Hepatitis C Treatment & Management (B. Anand, MD, Ed.). Medscape, 1-15. Retrieved August 6, 2015, from http://emedicine.medscape.com/article/177792-treatment
• Huffman, M., & Mounsey, A. (2014). Hepatitis C for Primary Care Physicians. The Journal of the American Board of Family Medicine, 27(2), 284-291. Retrieved August 6, 2015, from http://www.jabfm.org/content/27/2/284.full
• Reau, N., & Graham, L. (2015). Hepatitis C: Screening, Identification, and Care. Digestive Disease Week, 1-5. Retrieved August 6, 2015, from http://www.medscape.com/viewarticle/848249